The Oxford Science Park

Find Out The Latest

Keep in touch with news and developments from The Oxford Science Park and its occupiers here.

You can also follow us on LinkedIn

Bond Williams expands at The Oxford Science Park to support innovation and growth

28 Nov 2025

Bond Williams Professional Recruitment is delighted to announce the expansion and relocation of its Oxford office to a larger space within the Magdalen Centre at Oxford Science Park. The move reflects the continued growth of its Engineering, Science & Space Division and commitment to supporting the region’s world-leading innovation ecosystem. For more than seven years, the Oxford team has partnered with pioneering organisations across... Read more

Scripta Therapeutics raises $12M to find disease-modifying drugs that alter transcription factor activity

13 Nov 2025

Scripta Therapeutics, based at The Oxford Science Park, has emerged from stealth by announcing a $12 million seed round to upend conventional approaches to drug discovery. Scripta combines AI, imaging, and patient-derived models to create and modulate disease maps based on transcriptional networks, building a new biology-first paradigm to decode and undo the programs that drive disease. The round is led jointly by Oxford Science... Read more

The Oxford Science Park acquires Northbrook House to further expand flexible lab space

11 Nov 2025

The Oxford Science Park (TOSP), one of the UK’s leading locations for science and technology companies, has announced the acquisition of Northbrook House, a prominent three-storey building, comprising 23,500 sq ft, on the eastern side of the Park. The property was acquired from Brydell Partners Series 2. Following refurbishment, Northbrook House will deliver flexible, high-quality laboratory and write-up accommodation designed to meet the... Read more

Enara Bio announces discovery of new cancer specific dark antigen

06 Nov 2025

Enara Bio has identified a new cancer-specific marker, called DARKFOX, that the company says could broaden the reach of next-generation immunotherapies for solid tumours. DARKFOX is a protein fragment displayed on the surface of many solid tumour cells - including most lung, head and neck, and oesophageal squamous cell cancers - while appearing at very low levels in healthy tissue. According to Enara, this combination of broad tumour coverage... Read more

The Oxford Science Park welcomes Cowley Branch Line announcement

23 Oct 2025

The Oxford Science Park (TOSP) has welcomed today’s announcement by the Chancellor of the Exchequer, Rachel Reeves, confirming government funding of £120m for the reopening of the Cowley Branch Line to passengers. The decision marks a significant milestone in improving transport links for Oxford’s growing innovation district. The project will reconnect Cowley and Littlemore with Oxford city centre and beyond through two new stations with one... Read more

News